• Current and Emerging Treatments for Advanced Cutaneous Melanoma: Pharmacist Pearls
  Three dates to choose from: April 22, 27, 29

• The Psychology and Neuroscience of Adherence and Compliance

• The Era of Targeted Therapy in Severe Asthma: Specialty Pharmacy Perspectives 
• Update on Treatment of Moderate to Severe Asthma with Biologics

• Introduction to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition 

• Cystic Fibrosis Module #1: Cystic Fibrosis: An Overview for Pharmacists  
• Cystic Fibrosis Module #2: Chronic Medications: Changing the Course of Cystic Fibrosis  
• Cystic Fibrosis Module #3: Management of Acute Pulmonary Exacerbations: Pseudomonas and Beyond  
• Cystic Fibrosis Module #4: Adherence, Access, Education: Current Challenges and Overcoming Barriers in CF Medications  

• Certification in Specialty Pharmacy Exam - Preparation Course 

• Fertility Module #1: Fertility Care Considerations: Introduction to Infertility for the Specialty Health Care Pharmacist  
• Fertility Module #2: Infertility: Therapeutics and Medication Profiles  
• Fertility Module #3: Infertility: Protocols and Patient Management  
• Fertility Module #4: Fertility Care Considerations: Infertility: Special Populations and Considerations  

• Enzyme Replacement Therapies
• An Introduction to Gene and Disease-modifying Therapies in Specialty Pharmacy
• Overview of Gene Therapy and the Pharmacist’s Role

• Optimization of IVIG and SCIG: Patient Centered Care and the Role of Specialty Pharmacies  
• Hemophilia in Specialty Pharmacy  
• Practical Guidance for Surveillance and Reporting in Hemophilia A 
• What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment 

• Hepatitis C Module #1: The abCs of HCV  
• Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C  
• Hepatitis C Module #3: HCV Drug Therapy Management  
• Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy  

• Management of Peanut Allergy  

• Outsmarting Multi-Drug Resistance in Uncertain Times 

• Chronic Inflammatory Disease: An Introduction  
• Psoriasis and Psoriatic Arthritis  
• IBD: Medication and Patient Management  
• Rheumatoid Arthritis  
• Moderate to Severe Atopic Dermatitis: An Update for Pharmacists 

• Treatment Strategies and Safety Updates in Multiple Sclerosis  
• MS-101: Pathogenesis, Diagnostic and Clinical Course Treatment Considerations in MS (A CSPE Core Curriculum Series) 
• MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series) 
• MS-103: The Role of the Specialty Pharmacy Professional in Managing MS Treatment: Care Transitions, Patient Education/Adherence, and Financial Considerations (A CSPE Core Curriculum Series) 
• MS-104: Optimizing MS Treatment: Case Studies and Applications in Specialty Pharmacy Practice (A CSPE Core Curriculum Series) 

• Adherence Concepts for the Cancer Patient 
• Prostate Cancer Treatment: Implications for the Pharmacist 
• Chemotherapy-Induced Nausea and Vomiting and Oral Chemotherapy Related Adverse Events 
• Ovarian Cancer: Implications for the Pharmacist 
• Nutrition in Cancer Care  
• Targeted Oral Chemotherapy for Lung Cancer 
• Contemporary Evaluation and Management of Lung Cancer Targeted Therapies 
• Melanoma Diagnosis and Management Considerations 
• Colorectal Cancer 
• A Review in the Treatment Options for Renal Cell Cancer 

• Strategies to Eliminate Errors in IV Compounding 
• Arming Specialty Pharmacies with Standards-Based Technologies to Engage Patients and Prescribers  
• Mobile Patient Engagement: Using Technology to Break Barriers and Reach Patients in New Ways  

• Opioid Use Disorder: Treatment and Recovery Options 

• Pulmonary Arterial Hypertension: Individualized Treatment Strategies 
• Management and Trends in Pulmonary Arterial Hypertension 
• Expert Perspectives in Pulmonary Arterial Hypertension: Health-System Considerations 
• Interprofessional Considerations in the Management of Pulmonary Arterial Hypertension 

• The Pharmacy Technician’s Role in the Management of the Specialty Pharmacy Patient  
• Billing and Financial Assistance in Specialty Pharmacy  
• Multiple Sclerosis and Role of Specialty Pharmacy  
• Oral Oncology - Clinical Module for Pharmacy Technicians, Part 1  
• Oral Oncology - Clinical Module for Pharmacy Technicians, Part 2  
• Hepatitis C: A Technician’s Guide  
• Specialty Technician CE: Cystic Fibrosis  
• Specialty Technician CE: Inflammatory Module  
• Documentation and Communication Etiquette

• Treatment of Rare Seizure Disorders within Specialty Pharmacy  

  NASP Annual Meeting On-Demand Sessions
   Click the links below to view the available sessions from NASP Annual Meetings,
   some content is available to NASP members only.

• State of Care: Cystic Fibrosis  
• State of Care: Hepatology  
• State of Care: Inflammatory Diseases  
• State of Care: Oncology/Hematology  
• Biosimilar Action Plan  
• A Specialty Pharmacy Pipeline Product Update  

• State of Care 2020: Autoimmune Disorders  
• State of Care 2020: HIV  
• State of Care 2020: Immune Globulin  
• State of Care 2020: Oral Oncology  
• State of Care 2020: Transplant  
• 340B Drug Pricing - Update on Legislative, Regulatory and Political Landscape  
• Building Partnerships with Drug Manufacturers & Payors: How Health System Specialty Pharmacies Can Use Data to Enhance Care & Create Synergies with Stakeholders  
• Copay Accumulators, Maximizers, and the Impact for Specialty  
• Maximizing Automation and Technology Innovation  
• Specialty Pharmaceutical Pipeline Updates  
• Utilizing Technology for Patient Communication in Specialty  

National Association of Specialty Pharmacy
300 New Jersey Avenue NW, Suite 900
Washington, DC 20001
Email: info@naspnet.org
Phone: 703.842.0122

ProCE, LLC
12001 Sunrise Valley Drive, Ste 300
Reston, VA 20191
Email: info@proce.com
Phone: 888.213.4061